Not Rated
|
Fund Size
(1.21% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 28-Oct-25 | 10045.90 | 0.46% | - | -0.29% | 34/227 |
| 1 Month | 03-Oct-25 | 10248.30 | 2.48% | - | 2.36% | 103/227 |
| 3 Month | 04-Aug-25 | 10092.30 | 0.92% | - | 4.12% | 200/223 |
| 6 Month | 02-May-25 | 10962.20 | 9.62% | - | 10.72% | 107/213 |
| YTD | 01-Jan-25 | 10132.00 | 1.32% | - | 5.29% | 130/201 |
| 1 Year | 04-Nov-24 | 10624.10 | 6.24% | 6.24% | 5.81% | 79/187 |
| 2 Year | 03-Nov-23 | 17190.60 | 71.91% | 31.02% | 21.73% | 9/141 |
| 3 Year | 04-Nov-22 | 20853.20 | 108.53% | 27.73% | 20.47% | 13/117 |
| 5 Year | 04-Nov-20 | 26628.10 | 166.28% | 21.62% | 23.49% | 50/92 |
| Since Inception | 13-Jul-18 | 43750.00 | 337.50% | 22.35% | 14.61% | 27/219 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 04-Nov-24 | 12000 | 12781.1 | 6.51 % | 12.22 % |
| 2 Year | 03-Nov-23 | 24000 | 28866.96 | 20.28 % | 18.8 % |
| 3 Year | 04-Nov-22 | 36000 | 53122.29 | 47.56 % | 26.92 % |
| 5 Year | 04-Nov-20 | 60000 | 106018.27 | 76.7 % | 22.93 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 7211.9 | 11.58% | -0.12% | 14.35% (Oct 2024) | 11.58% (Sep 2025) | 45.24 L | 0.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 5669.5 | 9.10% | -0.37% | 9.66% (May 2025) | 8.28% (Jan 2025) | 46.33 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 5449.1 | 8.75% | -0.48% | 9.23% (Aug 2025) | 1.86% (Nov 2024) | 9.58 L | 29.82 k |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 5137.3 | 8.25% | 1.72% | 8.25% (Sep 2025) | 4.57% (Oct 2024) | 47.40 L | 8.27 L |
| Cipla Ltd. | Pharmaceuticals | 4309.4 | 6.92% | -0.47% | 9.71% (Jan 2025) | 6.92% (Sep 2025) | 28.67 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 3382.3 | 5.43% | -0.01% | 5.44% (Aug 2025) | 3.79% (Jun 2025) | 17.70 L | 0.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 2523.5 | 4.05% | 0.05% | 4.49% (Feb 2025) | 1.63% (Oct 2024) | 4.65 L | 0.00 |
| Biocon Ltd. | Pharmaceuticals | 1937 | 3.11% | -0.10% | 5.02% (Jun 2025) | 1.36% (Feb 2025) | 56.80 L | 0.00 |
| Gland Pharma Ltd. | Pharmaceuticals | 1848.2 | 2.97% | 0.09% | 4.38% (Nov 2024) | 2.88% (Aug 2025) | 9.28 L | -0.19 L |
| Mankind Pharma Ltd. | Pharmaceuticals | 1834.1 | 2.95% | -0.56% | 4.2% (Jun 2025) | 0.62% (Nov 2024) | 7.53 L | -1.20 L |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.58% |
| Margin | Margin | 0.13% |
| Net Receivables | Net Receivables | -0.26% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 406.67 | 1.34 | 26.29 | 63.29 | 46.69 | 41.91 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 266.19 | -1.14 | 5.42 | 20.17 | 30.13 | 18.93 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 289.73 | 1.05 | 8.61 | 18.40 | 22.70 | 20.55 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1651.55 | 1.08 | 11.03 | 29.10 | 22.29 | 0.00 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 279.13 | 2.24 | 12.23 | 24.61 | 22.00 | 17.31 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7024.28 | 0.27 | 6.46 | 18.11 | 20.13 | 0.00 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1419.62 | 4.00 | 6.90 | 10.70 | 19.63 | 0.00 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 655.17 | 3.03 | 4.42 | 20.17 | 19.07 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 311.03 | 5.15 | 7.04 | 9.15 | 18.85 | 15.83 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 8693.07 | 3.34 | 6.04 | 10.94 | 17.69 | 20.70 |
Out of 108 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 9 is/are ranked 3 * , 5 is/are ranked 2 * , 3 is/are ranked 1 * , and 77 schemes are not ranked. See more about AMC